Trials / Unknown
UnknownNCT03322189
Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)
Medical Provider Experience and Assessment on Documenting Prescribing and Plan of Care Changes Due to Pharmacogenomics Testing
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Data Collection Analysis Business Management · Academic / Other
- Sex
- All
- Age
- 18 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
Current providers' standard operating procedures on pharmacogenomic testing patients
Detailed description
The general design of this study is collecting data and reviewing Principal Investigators' Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific SOP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | pharmacogenomic | Standard Operating Procedures on Pharmacogenomic testing and changes made to specific SOP |
Timeline
- Start date
- 2017-03-22
- Primary completion
- 2020-03-22
- Completion
- 2020-04-01
- First posted
- 2017-10-26
- Last updated
- 2019-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03322189. Inclusion in this directory is not an endorsement.